Pipeline
Our lead program is a best-in-class positive allosteric modulator (PAM) that targets the α5-GABA-A receptor.
Cognitive deficits—impairments in the ability to
understand, remember, and think clearly—
result from loss of connections between brain cells.
Damona is developing therapies that reverse cognitive deficits, restore contact between brain cells, and improve life for the significant number of patients living with cognitive deficits.
